United States · FDA National Drug Code directory
Dasatinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66993-235_19048218-75dd-45fc-8e6e-fc660d861fb7
- Product NDC
- 66993-235
- Form
- TABLET
- Composition / generic term
- dasatinib
- Labeler
- Prasco Laboratories
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20240903
- Source listing expiry
- 20261231
Source-listed ingredients
- DASATINIB — 70 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (66993-235-60) / 60 TABLET in 1 BOTTLE · 66993-235-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →